PPARG and urinary bladder carcinoma: Similarly, treatment with the PPAR-γ agonist 15d-PGJ2 significantly suppressed spheroid formation and reduced the expression of stemness-related genes in bladder cancer cells [136], as well as in glioma and glioblastoma stem cells [137,138].